Professor Nick   Di Girolamo
Professor

Professor Nick Di Girolamo

1983-1985

BSc University of Sydney (conferred 1986)

 

1995-1997

PhD University of New South Wales (conferred 1998)

Title: Mechanisms of Tissue Destruction in Inflammatory Eye Disease

 

medicine-health
School of Medical Sciences

Professor Nick Di Girolamo is Director of the Ocular Diseases Research Unit and Head of the Mechanisms of Disease and Translational Research, School of Medical Sciences, University of New South Wales. Nick leads an internationally recognised group whose mission is to restore sight in patients blinded from severe corneal disease. His research program integrates basic sciences, revolutionary animal models, and world-first clinical trials using adult stem cells; the results of which have demonstrated improved eye health and vision in patients. Nick has received two decades of continuous funding from the NHMRC and other national and international funding agencies and has 120 peer reviewed published articles.

Broad Research Areas:
Stem Cells, Ophthalmology, Transplantation, Pathology, Inflammation

Qualifications:
BSc, PhD

Society Memberships & Professional Activities:
1. Association for Research in Vision and Ophthalmology (ARV0),

2. International Ocular Inflammation Society (IOIS),

3. Sydney Tissue Engineering and Matrix group (STEAM),

4. Australian Society for Medical Research (ASMR),

5. Member, NHMRC GRP Panels(Autonomic/Peripheral & Sensory Nervous System; Surgery/Dental/Medical & Related Technologies),

6. Member, ORIA Research Advisory Committee,

7. Editorial board Member, Ocular Surface

8.Member of the TGA Advisory Committee on Biologicals

Specific Research Keywords:
Corneal Stem Cell Biology, Stem Cell Therapy, Ocular Surface Disease, Ultraviolet Radiation, Dry Eye Disease

Location
Wallace Wurth (East) Building (C27)

Publications

Awards

 

  1. ABC’s New Inventors (02-06-09) Episode winner and People’s Choice.
  2. Finalist and winner (23-11-09) of “Less is More Award” awarded to an inventor whose invention impacts the community or environment.
  3. Finalist 2010 UNSW Inventor of the Year (Biomedical)
  4. First Prize, Association for Research in Vision and Ophthalmology ARVO-Scientific Image Contest winner. 2016 Migrating Multicolored Corneal Epithelia
  5. School of Medical Sciences, Researcher of the Year (2019)

Grants

Project Grants for Research (2015- )

2015

UNSW Goldstar Award

Mapping the fate of corneal epithelial stem cells in health and disease

CIA-Di Girolamo N.

$40,000 total

 

2015

Ophthalmic Research Institute of Australia

ORIA/Renensson Bequest Grant

Destiny of limbal epithelial stem cells in the normal cornea

CIA-Di Girolamo N.

$50,000 total

 

2015-2016

Kylaco PTY LTD

Spondyathropathies (spas) peptide vaccine

CIA-Marcal, CIB-Wakefiled, CIC-Di Girolamo

$200,000 total

 

2016-2019

NHMRC Project Grant APP1101078

Mapping the dynamics of corneal stem cells during aging and after wounding and transplantation

CIA-Di Girolamo, CIB-Watson, CIC-Wakefield

$548,903 total

 

2016

UNSW Goldstar Award

Methods to mark and graft corneal stem cells to treat blindness

CIA-Di Girolamo N.

$40,000 total

 

2016-2017

Catholic Archdiocese of Sydney

Improving clinical outcomes for patients receiving corneal stem cell grafts

CIA-Di Girolamo N.

$100,000

 

2016-2017

Sao Paolo State Foundation for Research Support

Culturing human bone marrow-derived mesenchymal stem cells on Nanoskin scaffolds for ocular surface reconstruction

Schellini, Viveiros, Rainho, da Silva, Ximenes, Padovani, Basmaji, de Olyveira, Di Girolamo

AUD $75,000

 

2017-2018

Prince of Wales Hospital Foundation

Development of a vaccine to treat HLA B27 spondylarthritis (SpA)

CIA-Wakefield, CIB-Di Girolamo, CIC-Tedla

AUD $50,000

 

2018

Ophthalmic Research Institute of Australia

ORIA/Ivy May Stephenson Grant

A novel native scaffold for corneal epithelial regeneration

CIA-Di Girolamo N.

$49,500 total

 

2018-2019

Australia Research Council (ARC) Strategic Research Initiative Award

SR1101002 Stem Cell Australia: Transitioning into the future

Consortium of 65 CIs from 9 Australian Stakeholder Institutions and Partner Organizations (actual funds received $124,500)

$3,000,000 total

 

2019-2022      

NHMRC Project Grant APP1156944

Improving diagnostics and therapeutics for corneal blindness

CIA-Di Girolamo, CIB-Watson, CIC-Wakefield

$827,204 total

 

2019-2021

Medical Research Future Fund (MRFF) Accelerator Research Stem Cell Program

Stem cells for sight: building the pathway from the lab to the clinic

Watson, Di Girolamo, O’Connor, Munsie, Jamieson, Chow, Harkin

$425,000 total

 

2021-2022      

Diabetes Australia. A Novel treatment for type 1 diabetes that regenerates sensory nerves: using the eye as a model.  

CIA-Di Girolamo, CIB-Rye, CIC-Cochran, CID-Park

$60,000

Media